C9orf57
gene geneOn this page
Summary
C9orf57 (chromosome 9 open reading frame 57, HGNC:27037) is a protein-coding gene on chromosome 9q21.13, encoding Uncharacterized protein C9orf57 (Q5W0N0).
Predicted to be located in membrane.
Source: NCBI Gene 138240 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 3 total — 1 pathogenic
- MANE Select transcript:
NM_001128618
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27037 |
| Approved symbol | C9orf57 |
| Name | chromosome 9 open reading frame 57 |
| Location | 9q21.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000204669 |
| Ensembl biotype | protein_coding |
| Entrez | 138240 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 5 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000377024, ENST00000424431, ENST00000651121, ENST00000651200, ENST00000652156, ENST00000652752, ENST00000673779
RefSeq mRNA: 2 — MANE Select: NM_001128618
NM_001128618, NM_001371610
CCDS: CCDS47980
Canonical transcript exons
ENST00000651200 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001472523 | 72056074 | 72056196 |
| ENSE00001472527 | 72056784 | 72056843 |
| ENSE00001876908 | 72051376 | 72052435 |
| ENSE00003843056 | 72059235 | 72059384 |
| ENSE00003848877 | 72060497 | 72060613 |
Expression profiles
Bgee: expression breadth broad, 13 present calls, max score 84.40.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0509 / max 41.0487, expressed in 3 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 100937 | 0.0189 | 3 |
| 100938 | 0.0165 | 3 |
| 100939 | 0.0155 | 3 |
Top tissues by expression
231 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.40 | gold quality |
| right testis | UBERON:0004534 | 79.12 | gold quality |
| left testis | UBERON:0004533 | 78.27 | gold quality |
| testis | UBERON:0000473 | 76.89 | gold quality |
| adult organism | UBERON:0007023 | 76.05 | gold quality |
| ileal mucosa | UBERON:0000331 | 58.75 | silver quality |
| pancreatic ductal cell | CL:0002079 | 55.40 | silver quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| deltoid | UBERON:0001476 | 52.36 | gold quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| quadriceps femoris | UBERON:0001377 | 47.18 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 47.03 | gold quality |
| vastus lateralis | UBERON:0001379 | 45.40 | gold quality |
| skin of hip | UBERON:0001554 | 43.68 | silver quality |
| layer of synovial tissue | UBERON:0007616 | 43.55 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 42.72 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| muscle tissue | UBERON:0002385 | 42.52 | gold quality |
| sperm | CL:0000019 | 41.55 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| cartilage tissue | UBERON:0002418 | 40.77 | gold quality |
| amniotic fluid | UBERON:0000173 | 40.69 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
| biceps brachii | UBERON:0001507 | 40.57 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.45 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
51 targeting C9orf57, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-6870-5P | 99.99 | 68.55 | 2115 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-4723-5P | 99.97 | 68.70 | 2034 |
| HSA-MIR-5698 | 99.97 | 68.49 | 2029 |
| HSA-MIR-7111-5P | 99.97 | 68.48 | 2062 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-205-3P | 99.92 | 69.92 | 3165 |
| HSA-MIR-7162-3P | 99.89 | 68.16 | 1682 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4446-5P | 99.72 | 69.19 | 2544 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-494-3P | 99.70 | 71.45 | 2795 |
| HSA-MIR-5093 | 99.67 | 69.26 | 2291 |
| HSA-MIR-1827 | 99.63 | 68.57 | 3265 |
| HSA-MIR-7152-5P | 99.60 | 69.33 | 2094 |
| HSA-MIR-4261 | 99.59 | 70.30 | 3415 |
| HSA-MIR-3942-3P | 99.57 | 69.03 | 2854 |
| HSA-MIR-4328 | 99.57 | 71.06 | 4094 |
| HSA-MIR-4649-3P | 99.56 | 66.90 | 1783 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Uncharacterized protein C9orf57 — Q5W0N0 (reviewed: Q5W0N0)
All UniProt accessions (4): Q5W0N0, A0A494C027, A0A494C0F4, A0A494C1R2
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5W0N0-1 | 1 | yes |
| Q5W0N0-2 | 2 |
RefSeq proteins (2): NP_001122090, NP_001358539 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031710 | DUF4723 | Family |
Pfam: PF15851
UniProt features (3 total): chain 1, transmembrane region 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5W0N0-F1 | 69.04 | 0.20 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 20 (showing top):
chr9q21, ZNF274_TARGET_GENES, MIR4328, MIR4306, MIR1827, MIR3942_3P, MIR4446_5P, MIR6868_3P, MIR4723_5P, MIR6870_5P, MIR7111_5P, MIR5698, MIR6876_5P, MIR4476, MIR4649_3P
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
42 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C9orf57 | C9orf85 | Q96MD7 | 716 |
| C9orf57 | ABHD17B | Q5VST6 | 577 |
| C9orf57 | ZFAND5 | O76080 | 507 |
| C9orf57 | CEMIP2 | Q9UHN6 | 448 |
| C9orf57 | TRPM3 | Q9HCF6 | 336 |
| C9orf57 | TMC2 | Q8TDI7 | 287 |
| C9orf57 | TJP2 | Q9UDY2 | 272 |
| C9orf57 | GJB2 | P29033 | 271 |
| C9orf57 | TMC8 | Q8IU68 | 264 |
| C9orf57 | ANXA1 | P04083 | 222 |
| C9orf57 | SLC25A15 | Q9Y619 | 213 |
| C9orf57 | MYO15A | Q9UKN7 | 203 |
| C9orf57 | ALDH1A1 | P00352 | 202 |
| C9orf57 | OTOF | Q9HC10 | 192 |
| C9orf57 | CDH23 | Q9H251 | 160 |
IntAct
1 interactions, top by confidence:
BioGRID (3): C9orf57 (Two-hybrid), GPSM3 (Two-hybrid), C9orf57 (Positive Genetic)
ESM2 similar proteins: A0A0J9YY54, A4K2M6, A4K2P0, A4K2P8, A4K2T3, A4K2U1, A4K2Y4, A6NF34, A6NI47, B3A0S1, D1FNK2, D3YZV8, D9IX97, O43493, P16225, P19957, P26436, P62521, Q06990, Q0P6D6, Q27J49, Q28139, Q29125, Q29126, Q4R729, Q4ZJY8, Q5F378, Q5JRC9, Q5QGU6, Q5SRN2, Q5W0N0, Q63HK3, Q6H9L7, Q6IC83, Q6S545, Q7M3V1, Q8BVC1, Q8CHN3, Q8N2N9, Q8N660
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 59107 | GRCh38/hg38 9q21.13(chr9:72023067-72497412)x1 | Pathogenic |
SpliceAI
465 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:72056844:C:CC | acceptor_gain | 0.9900 |
| 9:72060496:CCTAT:C | donor_gain | 0.9900 |
| 9:72060500:T:C | donor_gain | 0.9900 |
| 9:72056200:CAAG:C | acceptor_gain | 0.9700 |
| 9:72056203:G:GC | acceptor_gain | 0.9700 |
| 9:72056213:A:T | acceptor_gain | 0.9700 |
| 9:72056856:CA:C | acceptor_gain | 0.9700 |
| 9:72056203:G:C | acceptor_gain | 0.9600 |
| 9:72056206:C:CT | acceptor_gain | 0.9600 |
| 9:72056212:C:CT | acceptor_gain | 0.9600 |
| 9:72056855:CCA:C | acceptor_gain | 0.9600 |
| 9:72060492:CCTA:C | donor_loss | 0.9600 |
| 9:72060493:CTAC:C | donor_loss | 0.9600 |
| 9:72060494:TAC:T | donor_loss | 0.9600 |
| 9:72060495:ACC:A | donor_loss | 0.9600 |
| 9:72056844:CTAAA:C | acceptor_loss | 0.9500 |
| 9:72056845:T:A | acceptor_loss | 0.9500 |
| 9:72056857:A:C | acceptor_gain | 0.9400 |
| 9:72059322:T:TA | donor_gain | 0.9400 |
| 9:72052434:ACC:A | acceptor_loss | 0.9300 |
| 9:72052435:CCT:C | acceptor_loss | 0.9300 |
| 9:72052436:C:A | acceptor_loss | 0.9300 |
| 9:72052437:T:A | acceptor_loss | 0.9300 |
| 9:72056199:CCAAG:C | acceptor_gain | 0.9300 |
| 9:72056207:A:T | acceptor_gain | 0.9300 |
| 9:72056839:CAGGT:C | acceptor_gain | 0.9300 |
| 9:72056853:A:T | acceptor_loss | 0.9300 |
| 9:72056237:A:C | acceptor_gain | 0.9200 |
| 9:72060490:GACCT:G | donor_loss | 0.9200 |
| 9:72060491:ACCTA:A | donor_loss | 0.9200 |
AlphaMissense
893 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:72052422:C:A | W120C | 0.972 |
| 9:72052422:C:G | W120C | 0.972 |
| 9:72056150:G:C | F90L | 0.961 |
| 9:72056150:G:T | F90L | 0.961 |
| 9:72056152:A:G | F90L | 0.961 |
| 9:72052424:A:G | W120R | 0.954 |
| 9:72052424:A:T | W120R | 0.954 |
| 9:72056169:C:T | C84Y | 0.930 |
| 9:72052405:C:G | C126S | 0.929 |
| 9:72052406:A:T | C126S | 0.929 |
| 9:72052380:G:C | F134L | 0.925 |
| 9:72052380:G:T | F134L | 0.925 |
| 9:72052382:A:G | F134L | 0.925 |
| 9:72056178:C:G | C81S | 0.919 |
| 9:72056179:A:T | C81S | 0.919 |
| 9:72052384:C:G | C133S | 0.917 |
| 9:72052385:A:T | C133S | 0.917 |
| 9:72056179:A:G | C81R | 0.917 |
| 9:72056177:G:C | C81W | 0.916 |
| 9:72056178:C:T | C81Y | 0.915 |
| 9:72056169:C:G | C84S | 0.913 |
| 9:72056170:A:T | C84S | 0.913 |
| 9:72056142:C:G | C93S | 0.902 |
| 9:72056143:A:T | C93S | 0.902 |
| 9:72052306:C:G | C159S | 0.901 |
| 9:72052307:A:T | C159S | 0.901 |
| 9:72052385:A:G | C133R | 0.900 |
| 9:72056143:A:G | C93R | 0.900 |
| 9:72056168:G:C | C84W | 0.892 |
| 9:72052299:G:C | F161L | 0.891 |
dbSNP variants (sampled 300 via entrez): RS1000108941 (9:72053397 A>G,T), RS1000292371 (9:72053703 C>T), RS1000555407 (9:72057868 A>G), RS1000652553 (9:72059482 T>C), RS1000897764 (9:72052071 A>G), RS1001003468 (9:72058177 T>A,C,G), RS1001201867 (9:72059572 A>G), RS1001221018 (9:72060872 T>C), RS1001320815 (9:72053504 C>T), RS1001437585 (9:72061640 C>A), RS1001517266 (9:72051708 A>G), RS1001563833 (9:72055129 G>A), RS1002422790 (9:72058420 C>G), RS1002891436 (9:72062245 T>C), RS1002994466 (9:72055135 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| propionaldehyde | decreases methylation | 1 |
| nonanal | decreases methylation | 1 |
| n-hexanal | decreases methylation | 1 |
| butyraldehyde | decreases methylation | 1 |
| caprylic aldehyde | decreases methylation | 1 |
| pentanal | decreases methylation | 1 |
| heptanal | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.